Cargando…
SPHK1在调节小细胞肺癌多药耐药中的作用
BACKGROUND AND OBJECTIVE: Lung cancer is the leading cause of cancer-related deaths worldwide. Approximately 15% of all histological types consist of small cell lung cancer (SCLC). Chemotherapy is one of the major treatment method. Though the current first-line standard chemotherapy regimen for SCLC...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000353/ https://www.ncbi.nlm.nih.gov/pubmed/25404266 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.11.01 |
Ejemplares similares
-
GRP78在肺腺癌细胞顺铂耐药中的作用
Publicado: (2010) -
EZH2抑制剂与吉非替尼联合应用在EGFR-TKIs耐药肺癌细胞中的作用研究
Publicado: (2019) -
干扰FOXC1逆转非小细胞肺癌吉非替尼耐药的作用
Publicado: (2021) -
异长春花碱逆转肺癌顺铂耐药A549/DDP细胞耐药性的作用和机制
Publicado: (2014) -
SOX4对非小细胞肺癌细胞A549的顺铂耐药作用的影响
Publicado: (2017)